Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
1,1 Diphenyl 2 Picrylhydrazyl
16%
Abamectin
38%
ABTS
16%
Adverse Event
55%
Alloxan
9%
Anti-Inflammatory Drug
16%
Anticonvulsive Agent
38%
Antiinflammatory Activity
38%
Antioxidant Capacity
10%
Bacilli
12%
Biological Marker
84%
Biopharmaceutical
38%
Carbamazepine
15%
Carrageenan
10%
CYP2C19
38%
CYP2C8
38%
CYP2C9
38%
CYP2C9*3
23%
CYP3A4
38%
Cytochrome P450 1A1
38%
Detoxication
8%
Diseases
7%
Docetaxel
38%
Drug Metabolism
7%
Enzyme Immunoassay
11%
Epidermolysis
7%
Epilepsy
100%
Experimental Hyperglycemia
9%
Flavonoid
38%
Glibenclamide
9%
Grape
38%
Hyperammonemia
7%
Inflammation
38%
Malignant Neoplasm
15%
Neurologic Disease
7%
Neuropathy
38%
Paclitaxel
38%
Pharmacogenetics
41%
Pharmacotherapy
11%
Phenytoin
46%
Prevalence
38%
Rat
10%
Risperidone
38%
Schizophrenia
38%
Senna alata
38%
SLCO1B1
38%
Sodium Valproate
53%
Stevens Johnson Syndrome
7%
Tablet
38%
Therapeutic Drug Monitoring
11%
Keyphrases
Acute Inflammation
38%
Adverse Effects
10%
Anti-inflammatory Activity
10%
Anti-inflammatory Effect
38%
Antioxidant Activity
43%
Aqueous Cinnamon Extract
9%
Biosorbent
11%
Biosorption
38%
Carrageenan
10%
Chitin
38%
Chitosan
38%
Correlation Relationship
11%
CYP2C19*2
9%
CYP2C19*3
9%
CYP2C9*2
19%
CYP2C9*3
28%
Cytochrome P450 2C9 (CYP2C9)
38%
Dissolution Percentage
12%
Dose Proportionality
12%
Drug Dosage
9%
Evergreen Tree
9%
Gene Encoding
9%
Genetic Biomarkers
38%
Glyphosate
38%
Hydroalcoholic Extract
38%
Ica Valley
76%
Intermediate Metabolizer
9%
OH Groups
11%
People with Epilepsy
38%
Permissible Limit
19%
Permissible Value
38%
Peru
38%
Pharmaceutical Quality Control
38%
Pharmacogenes
38%
Phase Weight
12%
Phenytoin
38%
Pisco
38%
Pisco Industry
9%
Polyphenols
38%
Quality Control Measures
12%
Roxb
38%
Saliva
38%
Senna Alata
38%
Severe Cutaneous Adverse Reactions
9%
Silver Ions
38%
Total Flavonoid Content
57%
Total Polyphenol Content
19%
Total Polyphenolic Content
21%
Verum
38%
Wine
38%